World Sepsis Day is a Global Sepsis Alliance initiative that started in 2012 and occurs every year on September 13th with events held all over the world to raise awareness about sepsis.

World Sepsis Day is important because it is an opportunity for people worldwide to unite in the fight against sepsis which accounts for at least 8 million deaths worldwide annually [1]. Yet, depending on the country and education, sepsis is known only to 7 – 50% of the people [2]. It is also poorly known that sepsis can be prevented by vaccination and that early recognition and treatment reduce sepsis mortality by 50% [3].  This lack of knowledge makes sepsis the number one preventable cause of death worldwide.

Sepsis Awareness 

Is More Important Than Ever

In these unprecedented times, Sepsis Day is a moment for us to reflect on and recommit to focusing on the needs of the patient. Sepsis is the body's extreme response to an infection, and without timely treatment, sepsis can rapidly lead to tissue damage, organ failure, and death. During this challenging time we are facing because of the COVID-19 pandemic, it is important to reflect on the connections with sepsis. It is known that a patient with COVID-19 infection can have sepsis as a complication. But it is also important to highlight that because of the disruption of the healthcare system, it is possible that patients with sepsis have avoided seeking timely care due to fear of COVID-19. The COVID-19 pandemic has also uncovered valuable opportunities to improve the quality of care and patient safety that will help us even after the pandemic ends: from improving patient education, addressing racial and ethnic health disparities, and improving diagnostic testing and infection control.

Now is the time to act. We all have a role to play, and we must work together—across healthcare, government, research, public health, and more—to protect patients.  

Getein in Action

We have launched a series of sepsis testing products. Using our four tests CRP+PCT+SAA+IL-6, we help potential patients to detect sepsis in time and monitor the effect of treatment in real time after receiving treatment to protect the health of people around the world.

Reference:

[1] H Døllner; L Vatten; R Austgulen;  "Early Diagnostic Markers for Neonatal Sepsis: Comparing C-reactive Protein, Interleukin-6, Soluble Tumour Necrosis Factor Receptors and Soluble Adhesion Molecules.

[2] Mojca Groselj-Grenc; Alojz Ihan; Metka Derganc;  "Neutrophil and Monocyte CD64 and CD163 Expression in Critically Ill Neonates and Children with Sepsis: Comparison of Fluorescence Intensities and Calculated Indexes.

[3] K Shirakawa; K Naitou; J Hirose; M Nakamura; T Takeuchi; Y Hosaka; S Furusako;  "The New Sepsis Marker, SCD14-ST, Induction Mechanism in The Rabbit Sepsis Models".